Joubert syndrome is a neurodevelopmental disorder, characterized by malformation of the mid and hindbrain leading to the pathognomonic molar tooth appearance of the brainstem and cerebellum on axial MRI. Core clinical manifestations include hypotonia, tachypnea/apnea, ataxia, ocular motor apraxia, and developmental delay of varying degrees. In addition, a subset of patients has retinal dystrophy, chorioretinal colobomas, hepatorenal fibrocystic disease, and polydactyly. Joubert syndrome exhibits genetic heterogeneity, with mutations identified in more than 30 genes, including INPP5E, a gene encoding inositol polyphosphate 5-phosphatase E, which is important in the development and stability of the primary cilium. Here, we report the detailed clinical phenotypes of two sisters with a novel homozygous variant in INPP5E (NM_019892.4: c.1565G>C, NP_063945.2: p.Gly552Ala), expanding the phenotype associated with Joubert syndrome type 1. Expression studies using patient-derived fibroblasts showed changes in mRNA and protein levels. Analysis of fibroblasts from patients revealed that a significant number of cells had shorter or no cilia, indicating defects in ciliogenesis, and cilia maintenance.
The neuroradiological hallmark of JS is a the so called "molar tooth sign" (MTS) on axial brain MRI, which results from a specific constellation of mid and hindbrain malformations including cerebellar vermis hypoplasia, thick and abnormally oriented superior cerebellar peduncles, and unusually deep interpeduncular fossa. The finding of the MTS has been noted in prenatal imaging as early as 14-16 weeks of gestation, and considered to be associated with defective decussation of the superior cerebellar peduncles (Doherty, 2009 ).
Over the past several years, an increasing number of genes have been associated with Joubert syndrome, including INPP5E, which encodes 1,4,5-triphosphate (InsP3) 5-phosphatase, a 72 kDa protein that hydrolyzes the 5-phosphate of phosphatidylinositol 3,4,5-triphosphate, and phosphatidylinositol 4,5-diphosphate. INPP5E is concentrated in the axoneme of the primary cilium, and deregulation can alter cilia stability. Primary cilia are antenna-like structures that project from the surfaces of differentiated cells, participating in extracellular signal processing. Previous studies have shown that INPP5E plays a critical role in cilia by controlling ciliary growth and phosphoinositide 3-kinase (PI3K) signaling and stability (Jacoby et al., 2009) 
| MATERIALS AND METHODS
The patients were admitted to the National Institutes of Health Clinical Center (NIH-CC) and enrolled in protocol 76-HG-0238, "Diagnosis and The proband (Patient 1) was 19 years of age at initial evaluation. Perinatal history was uneventful; by 2 years of age she had no spoken words but hearing was normal. She was hypotonic and had delayed motor development; she first walked at 3.5 years of age. At school, she was placed in a special education setting because of a full scale IQ of 77. At age 19, she was able to vocalize approximately 10 single words and indicated her needs by pointing and using signs, although she was able to write names and numbers. She was independent in her activities of daily living. For instance, she took the city bus to school by herself and held a parttime job cleaning tables at a mall food court. There were no behavioral concerns. Upon examination, her head circumference was 58 cm (>99th centile, +3SD), height was 154.4 cm (9th centile), and weight was 67 kg (72nd centile). She had some facial dysmorphisms including high-arched eyebrows, small earlobes, and mild prognathism. Her neurological examination was notable for dysarthria, paucity of speech, mild dysmetria, and a mildly widebased gait. Brain MRI revealed the characteristic MTS (Figure 1b The younger affected sibling (Patient 2) was 18 years of age.
Her expressive speech was more severely impaired than her sister's. She had delayed motor development and began walking at 5 years of age. Although she did not present with spasticity, she walked on her toes was suspected to have tight heel cords, thus requiring tendon release surgery at 4 years of age. On examination, she communicated mostly with signs. Head circumference was 54.5 cm (57th centile), height 148.1 cm (1st centile, -2SD), weight 45 kg (3rd centile). She had upward slanting of the palpebral fissures, prominent lateral eyebrows and mild prognathism. Her neurological examination was notable for absent speech, though she was able to follow commands. She showed signs of dysmetria and dysdiadochokinesia in her upper and lower extremities. Her gait was mildly wide-based. As for her sister, her brain MRI showed a MTS (Figure 1b, left panel) .
On ocular examination, she had rotatory nystagmus, ocular motor apraxia, myopic astigmatism, and retinal degeneration (Figure 1b Our patients' mutation is located in the INPP5E catalytic domain but because our mutation is missense we do not anticipate complete loss of enzyme activity. Our patients' phenotype included mainly neurological and ocular involvement without evidence for kidney or liver disease consistent with prior reports of rare renal or hepatic involvement in patients with INPP5E mutations (Table 1 and   Supplementary Table S2 ). Still, it would be prudent to watch out for clinical signs of renal involvement, as four patients have been reported to have bilateral increased renal echogenicity with cysts or ectopia (Supplementary Table S2 ). Similarly, a routine examination of the liver may be helpful, as two patients were documented to have elevated transaminase levels and fibrosis (Supplementary Table S2 ). In terms of neurological symptoms, however, our patients seem to expand the clinical phenotype associated with INPP5E-related JS, as they exhibited more pronounced cerebellar signs, in addition to abnormalities recorded in evaluating auditory evoked potentials. Of note, both patients in this report have short stature, microsomia, and abnormal auditory brainstem response; whether this finding is specific to our patients in this report or included as one of the phenotypes associated with JS associated with INPP5E variants remains to be clarified. The possibility of having another genetic disorder, or a gene modifier, that could explain the occurrence of such symptoms, can only be addressed by future studies.
The INPP5E mutation in our patients may lead to the formation of an unstable protein, as supported by our biochemical data showing reduced levels of INPP5E in patients' fibroblasts, leading to impaired cilia formation. Indeed, the cilia present after 48 hr of serum starvation were shorter in both patients, and there were fewer total ciliated fibroblasts. The patients studied here have a missense INPP5E mutation and abnormal cilia length and number, highlighting the importance of INPP5E not only in cilia maintenance (Bielas et al., 2009 ), but also in ciliogenesis (Xu et al., 2016 (Xu et al., , 2017 . Our findings are supported by studies using animal models. Mice that lack Inpp5e are embryonic lethal; homozygous mice at E18.5 show several features of ciliopathies and in addition, show reduced cilia numbers and abnormal morphology in kidney tubules and Bowman's capsule (Jacoby et al., 2009) . Recently, INPP5E has been shown to coordinate with a centrosomal PtdIns(4)P 5-kinase, PIPKIγ, highlighting the importance of INPP5E in the initiation of ciliogenesis (Xu et al., 2016) . Our results are supported by recent studies showing defective ciliogenesis in inpp5e zebrafish morphants, which is reversed by PtdIns(3,4,5)P 3 inhibition (Xu et al., 2017) . In neural stem cells, INPP5E has been shown to regulate phosphoinositides; loss of INPP5E activity leads to accumulation of TULP3 (a protein required to traffic a subset of GPCRs to the cilium) and Gpr161, which ultimately lead to subsequent repression of Shh response (Chavez et al., 2015) . Future studies on Shh signaling pathways using fibroblasts from patients and controls will certainly contribute to the clarification of INPP5E function in regulating phosphoinositides.
The mid-hindbrain abnormalities observed in JS are considered to be a product of abnormalities in cell migration, as a result of the reduced functionality of the affected cilia (Doherty, 2009 ). Vermis hypoplasia in JS patients is considered to be a result of reduced proliferation and migration of germinal zone granule cell precursors, which later develop into granule neurons that do not align in a typical manner due to variations in signaling. While it is hypothesized that INPP5E defects can lead to aberrant cellular migration patterns during neonatal development, and some growth factors and morphogens in this altered this pathway have been identified, further studies will be necessary to elucidate the pathogenic mechanism linking cell migration to the disease morphology of JS patients (Valente, Rosti, Gibbs, & Gleeson, 2014) . Recent studies have identified further clues on the function of INPP5E, including regulation of lysosomal phosphoinositide balance for autophagosome-lysosome fusion Nakamura, Hasegawa, & Yoshimori, 2016) , and defects in kidney PI3K/Akt/mTORC1 signaling (Hakim et al., 2016) . Identification of other patients with INPP5E mutations will help us understand genotype and phenotype correlation and contribute to study design for future therapies. 
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